Skip to main content
Erschienen in: Virchows Archiv 4/2006

01.04.2006 | Review Article

How to define follicular thyroid carcinoma?

verfasst von: Kurt Werner Schmid, Nadir Rashad Farid

Erschienen in: Virchows Archiv | Ausgabe 4/2006

Einloggen, um Zugang zu erhalten

Abstract

The appropriate diagnosis of follicular thyroid carcinoma (FTC) still depends on its histological discrimination from follicular adenoma (including the distinction of benign from malignant oncocytic variants), papillary thyroid carcinoma (particularly from the follicular variants) and poorly differentiated thyroid carcinoma. The use of immunohistochemical markers contributed only marginally to better defining FTC. The introduction of the micro array technique, however, may offer the possibility of getting a better insight into the natural history, as well as predicting the clinical course, of a given thyroid nodule. This review attempts to recapitulate common standards in the diagnosis of FTC, to summarise current molecular data available to distinguish FTC from other benign and malignant tumours and, finally, to outline future perspectives to define FTC on its specific genetic features.
Literatur
1.
Zurück zum Zitat Albores-Saavedra J, Gould E, Vardaman C, Vuitch F (1991) The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 22:1195–1205CrossRefPubMed Albores-Saavedra J, Gould E, Vardaman C, Vuitch F (1991) The macrofollicular variant of papillary thyroid carcinoma: a study of 17 cases. Hum Pathol 22:1195–1205CrossRefPubMed
2.
Zurück zum Zitat Albores-Saavedra J, Carrick K (2004) Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 15:297–305CrossRefPubMed Albores-Saavedra J, Carrick K (2004) Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol 15:297–305CrossRefPubMed
3.
Zurück zum Zitat Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C (2003) Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63:2864–2871PubMed Aldred MA, Ginn-Pease ME, Morrison CD, Popkie AP, Gimm O, Hoang-Vu C, Krause U, Dralle H, Jhiang SM, Plass C, Eng C (2003) Caveolin-1 and caveolin-2, together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis. Cancer Res 63:2864–2871PubMed
4.
Zurück zum Zitat Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C (2004) Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 22:3531–3539CrossRefPubMed Aldred MA, Huang Y, Liyanarachchi S, Pellegata NS, Gimm O, Jhiang S, Davuluri RV, de la Chapelle A, Eng C (2004) Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes. J Clin Oncol 22:3531–3539CrossRefPubMed
5.
Zurück zum Zitat Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner MP (2000) Retinoblastoma expression in thyroid neoplasms. Mod Pathol 13:562–569CrossRefPubMed Anwar F, Emond MJ, Schmidt RA, Hwang HC, Bronner MP (2000) Retinoblastoma expression in thyroid neoplasms. Mod Pathol 13:562–569CrossRefPubMed
6.
Zurück zum Zitat Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL (1995) Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 4:113–121PubMedCrossRef Apel RL, Ezzat S, Bapat BV, Pan N, LiVolsi VA, Asa SL (1995) Clonality of thyroid nodules in sporadic goiter. Diagn Mol Pathol 4:113–121PubMedCrossRef
7.
Zurück zum Zitat Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ 3rd (2003) Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9:1792–1800PubMed Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ 3rd (2003) Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9:1792–1800PubMed
8.
Zurück zum Zitat Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F, Birnbaum D, Malthiery Y, Reynier P, Houlgatte R (2004) Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. J Clin Endocrinol Metab 89:994–1005CrossRefPubMed Baris O, Savagner F, Nasser V, Loriod B, Granjeaud S, Guyetant S, Franc B, Rodien P, Rohmer V, Bertucci F, Birnbaum D, Malthiery Y, Reynier P, Houlgatte R (2004) Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. J Clin Endocrinol Metab 89:994–1005CrossRefPubMed
9.
Zurück zum Zitat Baris O, Mirebeau-Prunier D, Savagner F, Rodien P, Ballester B, Loriod B, Granjeaud S, Guyetant S, Franc B, Houlgatte R, Reynier P, Malthiery Y (2005) Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma. Oncogene 24:4155–4461PubMed Baris O, Mirebeau-Prunier D, Savagner F, Rodien P, Ballester B, Loriod B, Granjeaud S, Guyetant S, Franc B, Houlgatte R, Reynier P, Malthiery Y (2005) Gene profiling reveals specific oncogenic mechanisms and signaling pathways in oncocytic and papillary thyroid carcinoma. Oncogene 24:4155–4461PubMed
10.
Zurück zum Zitat Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644–1650CrossRefPubMed Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644–1650CrossRefPubMed
11.
Zurück zum Zitat Berho M, Suster S (1997) The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 28:47–53CrossRefPubMed Berho M, Suster S (1997) The oncocytic variant of papillary carcinoma of the thyroid: a clinicopathologic study of 15 cases. Hum Pathol 28:47–53CrossRefPubMed
12.
Zurück zum Zitat Bronner MP, LiVolsi VA (1988) Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: microscopic features predict biological behaviour. Surg Pathol 1:137–150 Bronner MP, LiVolsi VA (1988) Oxyphilic (Askanazy/Hürthle cell) tumors of the thyroid: microscopic features predict biological behaviour. Surg Pathol 1:137–150
13.
Zurück zum Zitat Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743–1748CrossRefPubMed Canzian F, Amati P, Harach HR, Kraimps JL, Lesueur F, Barbier J, Levillain P, Romeo G, Bonneau D (1998) A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Am J Hum Genet 63:1743–1748CrossRefPubMed
14.
Zurück zum Zitat Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol 8:655–668PubMedCrossRef Carcangiu ML, Zampi G, Rosai J (1984) Poorly differentiated (“insular”) thyroid carcinoma. A reinterpretation of Langhans’ “wuchernde Struma”. Am J Surg Pathol 8:655–668PubMedCrossRef
15.
Zurück zum Zitat Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J (1991) Follicular Hurthle cell tumors of the thyroid gland. Cancer 68:1944–1953PubMedCrossRef Carcangiu ML, Bianchi S, Savino D, Voynick IM, Rosai J (1991) Follicular Hurthle cell tumors of the thyroid gland. Cancer 68:1944–1953PubMedCrossRef
16.
Zurück zum Zitat Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 113:1234–1242CrossRefPubMed Cerutti JM, Delcelo R, Amadei MJ, Nakabashi C, Maciel RM, Peterson B, Shoemaker J, Riggins GJ (2004) A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. J Clin Invest 113:1234–1242CrossRefPubMed
17.
Zurück zum Zitat Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL (2001) Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338–342CrossRefPubMed Cheung CC, Ezzat S, Freeman JL, Rosen IB, Asa SL (2001) Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol 14:338–342CrossRefPubMed
18.
Zurück zum Zitat Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK (2004) Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 10:6586–6597PubMedCrossRef Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK (2004) Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 10:6586–6597PubMedCrossRef
19.
Zurück zum Zitat Chung DH, Kang GH, Kim WH, Ro JY (1999) Clonal analysis of a solitary follicular nodule of the thyroid with the polymerase chain reaction method. Mod Pathol 12:265–271PubMed Chung DH, Kang GH, Kim WH, Ro JY (1999) Clonal analysis of a solitary follicular nodule of the thyroid with the polymerase chain reaction method. Mod Pathol 12:265–271PubMed
20.
Zurück zum Zitat D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100:1123–1129CrossRefPubMed D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, Siperstein AE, Duh QY, Clark OH (2004) Follicular thyroid carcinoma: histology and prognosis. Cancer 100:1123–1129CrossRefPubMed
21.
Zurück zum Zitat Evans HL, Vassilopoulou-Sellin R (1998) Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol 22:1512–1520CrossRefPubMed Evans HL, Vassilopoulou-Sellin R (1998) Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol 22:1512–1520CrossRefPubMed
22.
Zurück zum Zitat Finley DJ, Zhu B, Barden CB, Fahey TJ III (2004) Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg 240:425–437PubMedCrossRef Finley DJ, Zhu B, Barden CB, Fahey TJ III (2004) Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg 240:425–437PubMedCrossRef
23.
Zurück zum Zitat Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G (2001) Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158:987–996PubMed Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G (2001) Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol 158:987–996PubMed
24.
Zurück zum Zitat Garcia-Rostan G, Zhao H, Camp RL, Pollan M, Herrero A, Pardo J, Wu R, Carcangiu ML, Costa J, Tallini G (2003) ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 21:3226–3235CrossRefPubMed Garcia-Rostan G, Zhao H, Camp RL, Pollan M, Herrero A, Pardo J, Wu R, Carcangiu ML, Costa J, Tallini G (2003) ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol 21:3226–3235CrossRefPubMed
25.
Zurück zum Zitat Harach HR, Lesueur F, Amati P, Brown A, Canzian F, Kraimps JL, Levillain P, Menet E, Romeo G, Bonneau D (1999) Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. J Pathol 189:387–393CrossRefPubMed Harach HR, Lesueur F, Amati P, Brown A, Canzian F, Kraimps JL, Levillain P, Menet E, Romeo G, Bonneau D (1999) Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. J Pathol 189:387–393CrossRefPubMed
26.
Zurück zum Zitat Harrer P, Broecker M, Zint A, Schatz H, Zumtobel V, Derwahl M (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMed Harrer P, Broecker M, Zint A, Schatz H, Zumtobel V, Derwahl M (1998) Thyroid nodules in recurrent multinodular goiters are predominantly polyclonal. J Endocrinol Invest 21:380–385PubMed
27.
Zurück zum Zitat Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. International histological classification of tumours. Springer, Berlin Heidelberg New York Hedinger C, Williams ED, Sobin LH (1988) Histological typing of thyroid tumours. International histological classification of tumours. Springer, Berlin Heidelberg New York
28.
Zurück zum Zitat Hofstädter F (1980) Frequency and morphology of malignant tumours of the thyroid before and after the introduction of iodine-prophylaxis. Virchows Arch A Pathol Anat Histol 385:263–270CrossRefPubMed Hofstädter F (1980) Frequency and morphology of malignant tumours of the thyroid before and after the introduction of iodine-prophylaxis. Virchows Arch A Pathol Anat Histol 385:263–270CrossRefPubMed
29.
Zurück zum Zitat Johnson TL, Lloyd RV, Burney RE, Thompson NW (1987) Hurthle cell thyroid tumors. An immunohistochemical study. Cancer 59:107–112PubMedCrossRef Johnson TL, Lloyd RV, Burney RE, Thompson NW (1987) Hurthle cell thyroid tumors. An immunohistochemical study. Cancer 59:107–112PubMedCrossRef
30.
Zurück zum Zitat Katoh R, Harach HR, Williams ED (1998) Solitary, multiple, and familial oxyphil tumours of the thyroid gland. J Pathol 186:292–299CrossRefPubMed Katoh R, Harach HR, Williams ED (1998) Solitary, multiple, and familial oxyphil tumours of the thyroid gland. J Pathol 186:292–299CrossRefPubMed
31.
Zurück zum Zitat Kesmodel SB, Terhune KP, Canter RJ, Mandel SJ, LiVolsi VA, Baloch ZW, Fraker DL (2003) The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134:1005–1012CrossRefPubMed Kesmodel SB, Terhune KP, Canter RJ, Mandel SJ, LiVolsi VA, Baloch ZW, Fraker DL (2003) The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134:1005–1012CrossRefPubMed
32.
Zurück zum Zitat Kober F, Wolf G, Depisch D, Galvan G, Keminger K, Ladurner D, Langsteger W, Ogris E, Pimpl W, Roka R, Schmalzer E, Schmid KW, Tuchmann A (1990) Schilddrüsenkarzinom. In: Steindorfer P (ed) Manual der chirurgischen Krebstherapie. Springer, Berlin Heidelberg New York, pp 35–48 Kober F, Wolf G, Depisch D, Galvan G, Keminger K, Ladurner D, Langsteger W, Ogris E, Pimpl W, Roka R, Schmalzer E, Schmid KW, Tuchmann A (1990) Schilddrüsenkarzinom. In: Steindorfer P (ed) Manual der chirurgischen Krebstherapie. Springer, Berlin Heidelberg New York, pp 35–48
33.
Zurück zum Zitat Krohn K, Paschke R (2002) Somatic mutations in thyroid nodular disease. Mol Genet Metab 75:202–208CrossRefPubMed Krohn K, Paschke R (2002) Somatic mutations in thyroid nodular disease. Mol Genet Metab 75:202–208CrossRefPubMed
34.
Zurück zum Zitat Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246–255PubMedCrossRef Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246–255PubMedCrossRef
35.
Zurück zum Zitat LiVolsi VA (1990) Surgical pathology of the thyroid. Major problems in pathology, vol 22. Saunders, Philadelphia LiVolsi VA (1990) Surgical pathology of the thyroid. Major problems in pathology, vol 22. Saunders, Philadelphia
36.
Zurück zum Zitat LiVolsi VA (2003) Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 98:1997–1998CrossRefPubMed LiVolsi VA (2003) Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer 98:1997–1998CrossRefPubMed
37.
Zurück zum Zitat Ljungberg O, Bondeson L, Bondeson AG (1984) Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma. Hum Pathol 15:218–228PubMedCrossRef Ljungberg O, Bondeson L, Bondeson AG (1984) Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma. Hum Pathol 15:218–228PubMedCrossRef
38.
Zurück zum Zitat Mai KT, Elmontaser G, Perkin DG, Thomas J, Stinson WA (2005) Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma. Int J Surg Pathol 13:37–41PubMedCrossRef Mai KT, Elmontaser G, Perkin DG, Thomas J, Stinson WA (2005) Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma. Int J Surg Pathol 13:37–41PubMedCrossRef
39.
Zurück zum Zitat Marques AR, Espadinha C, Frias MJ, Roque L, Catarino AL, Sobrinho LG, Leite V (2004) Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours. Br J Cancer 91:732–738PubMed Marques AR, Espadinha C, Frias MJ, Roque L, Catarino AL, Sobrinho LG, Leite V (2004) Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours. Br J Cancer 91:732–738PubMed
40.
Zurück zum Zitat Maximo V, Sores P, Rocha AS, Sobrinho-Simoes M (1998) The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastruc Pathol 22:271–273 Maximo V, Sores P, Rocha AS, Sobrinho-Simoes M (1998) The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastruc Pathol 22:271–273
41.
Zurück zum Zitat Maximo V, Sobrinho-Simoes M (2000) Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch 437:107–115CrossRefPubMed Maximo V, Sobrinho-Simoes M (2000) Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch 437:107–115CrossRefPubMed
42.
Zurück zum Zitat Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 160:1857–1865PubMed Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 160:1857–1865PubMed
43.
Zurück zum Zitat Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simoes M (2005) Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92:1892–1898CrossRefPubMed Maximo V, Botelho T, Capela J, Soares P, Lima J, Taveira A, Amaro T, Barbosa AP, Preto A, Harach HR, Williams D, Sobrinho-Simoes M (2005) Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92:1892–1898CrossRefPubMed
44.
Zurück zum Zitat Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK (2004) Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 64:2898–2903CrossRefPubMed Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK (2004) Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 64:2898–2903CrossRefPubMed
45.
Zurück zum Zitat McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J (1996) Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120:1000–1004PubMedCrossRef McDonald MP, Sanders LE, Silverman ML, Chan HS, Buyske J (1996) Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120:1000–1004PubMedCrossRef
46.
Zurück zum Zitat Mendelsohn G (1988) Pathology of thyroid disease. In: Mendelsohn G (ed) Diagnosis and pathology of endocrine disease. J.B. Lippincott, Philadelphia, pp 37–117 Mendelsohn G (1988) Pathology of thyroid disease. In: Mendelsohn G (ed) Diagnosis and pathology of endocrine disease. J.B. Lippincott, Philadelphia, pp 37–117
47.
Zurück zum Zitat Miyake N, Maeta H, Horie S, Kitamura Y, Nanba E, Kobayashi K, Terada T (2001) Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas. Pathol Int 51:680–685CrossRefPubMed Miyake N, Maeta H, Horie S, Kitamura Y, Nanba E, Kobayashi K, Terada T (2001) Absence of mutations in the beta-catenin and adenomatous polyposis coli genes in papillary and follicular thyroid carcinomas. Pathol Int 51:680–685CrossRefPubMed
48.
Zurück zum Zitat Müller-Hocker J, Jacob U, Seibel P (1998) Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA. Ultrastruct Pathol 22:91–100PubMedCrossRef Müller-Hocker J, Jacob U, Seibel P (1998) Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4,977) of mitochondrial DNA. Ultrastruct Pathol 22:91–100PubMedCrossRef
49.
Zurück zum Zitat Musholt PB, Imkamp F, von Wasielewski R, Schmid KW, Musholt TJ (2003) RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hurthle cell carcinomas? Surgery 134:881–889CrossRefPubMed Musholt PB, Imkamp F, von Wasielewski R, Schmid KW, Musholt TJ (2003) RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hurthle cell carcinomas? Surgery 134:881–889CrossRefPubMed
50.
Zurück zum Zitat Nesland JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV (1985) Hurthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269–290PubMed Nesland JM, Sobrinho-Simoes MA, Holm R, Sambade MC, Johannessen JV (1985) Hurthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269–290PubMed
51.
Zurück zum Zitat Nibu K-I, Otsuko N, Nakao K, Sugasawa M, Rothstein JL (2005) RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas. Eur Arch Otorhinolaryngol 262:368–373CrossRefPubMed Nibu K-I, Otsuko N, Nakao K, Sugasawa M, Rothstein JL (2005) RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas. Eur Arch Otorhinolaryngol 262:368–373CrossRefPubMed
52.
Zurück zum Zitat Nikiforov YE (2004) Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinoma. Endocr Pathol 15:319–327CrossRefPubMed Nikiforov YE (2004) Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinoma. Endocr Pathol 15:319–327CrossRefPubMed
53.
Zurück zum Zitat Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE (2003) Ras point mutations and PAX8-PPAR gamma rearrangements in thyroid tumours: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318–2326CrossRefPubMed Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE (2003) Ras point mutations and PAX8-PPAR gamma rearrangements in thyroid tumours: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318–2326CrossRefPubMed
54.
Zurück zum Zitat Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G (1993) Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17:291–301PubMedCrossRef Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G (1993) Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17:291–301PubMedCrossRef
55.
Zurück zum Zitat Papotti M, Torchio B, Grassi L, Favero A, Bussolati G (1996) Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid. Am J Surg Pathol 20:686–694CrossRefPubMed Papotti M, Torchio B, Grassi L, Favero A, Bussolati G (1996) Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid. Am J Surg Pathol 20:686–694CrossRefPubMed
56.
Zurück zum Zitat Pilotti S, Collini P, Mariani L, Placucci M, Bongarzone I, Vigneri P, Cipriani S, Falcetta F, Miceli R, Pierotti MA, Rilke F (1997) Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21:1466–1473CrossRefPubMed Pilotti S, Collini P, Mariani L, Placucci M, Bongarzone I, Vigneri P, Cipriani S, Falcetta F, Miceli R, Pierotti MA, Rilke F (1997) Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol 21:1466–1473CrossRefPubMed
57.
Zurück zum Zitat Puskas LG, Farid NR (2004) Gene expression in thyroid tumors. In: Farid NR (ed) The molecular basis of thyroid cancer. Kluwer, Boston, pp 265–271 Puskas LG, Farid NR (2004) Gene expression in thyroid tumors. In: Farid NR (ed) The molecular basis of thyroid cancer. Kluwer, Boston, pp 265–271
58.
Zurück zum Zitat Puskas LG, Juhasz F, Farid NR (2004) Microarray study of malignant and benign nodular thyroid tissue. In: 86th annual meeting of the Endocrine Society, Abstract P2, New Orleans, p 183 Puskas LG, Juhasz F, Farid NR (2004) Microarray study of malignant and benign nodular thyroid tissue. In: 86th annual meeting of the Endocrine Society, Abstract P2, New Orleans, p 183
59.
Zurück zum Zitat Puskas LG, Juhasz F, Zarva A, Hackler L Jr, Farid NR (2005) Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. Mol Cell Biol 51:177–186 Puskas LG, Juhasz F, Zarva A, Hackler L Jr, Farid NR (2005) Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. Mol Cell Biol 51:177–186
60.
Zurück zum Zitat Raphael SJ (2002) The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol 13:301–311CrossRefPubMed Raphael SJ (2002) The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocr Pathol 13:301–311CrossRefPubMed
61.
Zurück zum Zitat Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland. Atlas of tumor pathology, 3rd series, vol 5. AFIP, Washington, DC Rosai J, Carcangiu ML, DeLellis RA (1992) Tumors of the thyroid gland. Atlas of tumor pathology, 3rd series, vol 5. AFIP, Washington, DC
62.
Zurück zum Zitat Rosai J (2004) Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 15:293–296CrossRefPubMed Rosai J (2004) Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact. Endocr Pathol 15:293–296CrossRefPubMed
63.
Zurück zum Zitat Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedCrossRef Sakamoto A, Kasai N, Sugano H (1983) Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849–1855PubMedCrossRef
64.
Zurück zum Zitat Schmid KW, Tötsch M, Hittmair A, Feichtinger H, Ladurner D, Hofstädter F (1989) Frequency of medullary thyroid carcinoma in an endemic area. Mod Pathol 2:90–93PubMed Schmid KW, Tötsch M, Hittmair A, Feichtinger H, Ladurner D, Hofstädter F (1989) Frequency of medullary thyroid carcinoma in an endemic area. Mod Pathol 2:90–93PubMed
65.
Zurück zum Zitat Schmid KW, Tötsch M, Öfner D, Böcker W, Ladurner D (1997) Minimally invasive follicular thyroid carcinoma. A clinico-pathological study. In: Schmid KW, Böcker W (eds) Thyroid pathology. Current topics in pathology. Springer, Berlin Heidelberg New York, pp 37–44 Schmid KW, Tötsch M, Öfner D, Böcker W, Ladurner D (1997) Minimally invasive follicular thyroid carcinoma. A clinico-pathological study. In: Schmid KW, Böcker W (eds) Thyroid pathology. Current topics in pathology. Springer, Berlin Heidelberg New York, pp 37–44
66.
Zurück zum Zitat Schmid KW (1998) Does the encapsulated oxyphilic variant of papillary thyroid carcinoma really exist? J Pathol 184:31ACrossRef Schmid KW (1998) Does the encapsulated oxyphilic variant of papillary thyroid carcinoma really exist? J Pathol 184:31ACrossRef
67.
Zurück zum Zitat Schmid KW, Sheu S-Y, Görges R, Ensinger C, Tötsch M (2003) Tumoren der Schilddrüse. Pathologe 24:357–372CrossRefPubMed Schmid KW, Sheu S-Y, Görges R, Ensinger C, Tötsch M (2003) Tumoren der Schilddrüse. Pathologe 24:357–372CrossRefPubMed
68.
Zurück zum Zitat Schröder S (1988) Pathologie und Klinik maligner Schilddrüsentumoren. Gustav Fischer Verlag, Stuttgart Schröder S (1988) Pathologie und Klinik maligner Schilddrüsentumoren. Gustav Fischer Verlag, Stuttgart
69.
Zurück zum Zitat Shaha AR, Loree TR, Shah JP (1995) Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131–1136PubMedCrossRef Shaha AR, Loree TR, Shah JP (1995) Prognostic factors and risk group analysis in follicular carcinoma of the thyroid. Surgery 118:1131–1136PubMedCrossRef
70.
Zurück zum Zitat Shahedian B, Shi Y, Zou M, Farid NR (2001) Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab 72:155–163CrossRefPubMed Shahedian B, Shi Y, Zou M, Farid NR (2001) Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations. Mol Genet Metab 72:155–163CrossRefPubMed
71.
Zurück zum Zitat Shi Y, Zou M, Varkondi E, Nagy A, Kozma L, Farid NR (2001) Cyclin D1 in thyroid carcinomas. Thyroid 10:741–746 Shi Y, Zou M, Varkondi E, Nagy A, Kozma L, Farid NR (2001) Cyclin D1 in thyroid carcinomas. Thyroid 10:741–746
72.
Zurück zum Zitat Sneed DC (1999) Protocol for the examination of specimens from patients with malignant tumors of the thyroid gland, exclusive of lymphomas. Arch Pathol Lab Med 123:45–49PubMed Sneed DC (1999) Protocol for the examination of specimens from patients with malignant tumors of the thyroid gland, exclusive of lymphomas. Arch Pathol Lab Med 123:45–49PubMed
73.
Zurück zum Zitat Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580CrossRefPubMed Soares P, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R, Sobrinho-Simoes M (2003) BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578–4580CrossRefPubMed
74.
Zurück zum Zitat Sobrinho-Simoes MA, Nesland JM, Holm R, Sambade MC, Johannessen JV (1985) Hurthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study. Ultrastruct Pathol 8:131–142PubMed Sobrinho-Simoes MA, Nesland JM, Holm R, Sambade MC, Johannessen JV (1985) Hurthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study. Ultrastruct Pathol 8:131–142PubMed
75.
Zurück zum Zitat Sobrinho-Simoes M, Maximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC (2005) Hurthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 13:29–35PubMedCrossRef Sobrinho-Simoes M, Maximo V, Castro IV, Fonseca E, Soares P, Garcia-Rostan G, Oliveira MC (2005) Hurthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 13:29–35PubMedCrossRef
76.
Zurück zum Zitat Stewart BW, Kleihues P (2003) World cancer report. IARC Press, Lyon, pp 257–260 Stewart BW, Kleihues P (2003) World cancer report. IARC Press, Lyon, pp 257–260
77.
Zurück zum Zitat Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2004) High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 90:1600–1605CrossRefPubMed Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2004) High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3 mRNA in thyroid follicular carcinomas. Br J Cancer 90:1600–1605CrossRefPubMed
78.
Zurück zum Zitat Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2005) Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 219:91–96CrossRefPubMed Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N (2005) Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. Cancer Lett 219:91–96CrossRefPubMed
80.
Zurück zum Zitat Thomas D, Lizyness M, Kuick R, Sanders D, Misek D, Hanash S, Nikiforov Y, Koenig R, Giorando TJ (2004) Gene expression signature of oncocytic (Hurthle cell) thyroid carcinoma. Thyroid 14:713 Thomas D, Lizyness M, Kuick R, Sanders D, Misek D, Hanash S, Nikiforov Y, Koenig R, Giorando TJ (2004) Gene expression signature of oncocytic (Hurthle cell) thyroid carcinoma. Thyroid 14:713
81.
Zurück zum Zitat Thomas GA, Williams D, Williams ED (1989) The clonal origin of thyroid nodules and adenomas. Am J Pathol 134:141–147PubMed Thomas GA, Williams D, Williams ED (1989) The clonal origin of thyroid nodules and adenomas. Am J Pathol 134:141–147PubMed
82.
Zurück zum Zitat Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Maximo V, Botelho T, Moreira S, Meireles AM, Magalhaes J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simoes M (2005) Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness. Virchows Arch 446:589–595CrossRefPubMed Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Maximo V, Botelho T, Moreira S, Meireles AM, Magalhaes J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simoes M (2005) Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness. Virchows Arch 446:589–595CrossRefPubMed
83.
Zurück zum Zitat Valenta LJ, Michel-Bechet M, Warshaw JB, Maloof F (1974) Human thyroid tumors composed of mitochondrion-rich cells: electron microscopic and biochemical findings. J Clin Endocrinol Metab 39:719–733PubMedCrossRef Valenta LJ, Michel-Bechet M, Warshaw JB, Maloof F (1974) Human thyroid tumors composed of mitochondrion-rich cells: electron microscopic and biochemical findings. J Clin Endocrinol Metab 39:719–733PubMedCrossRef
84.
Zurück zum Zitat Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M (1985) Papillary carcinoma. Semin Diagn Pathol 2:90–100PubMed Vickery AL Jr, Carcangiu ML, Johannessen JV, Sobrinho-Simoes M (1985) Papillary carcinoma. Semin Diagn Pathol 2:90–100PubMed
85.
Zurück zum Zitat Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, Torchio B, Papotti MG (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100:950–957CrossRefPubMed Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, Torchio B, Papotti MG (2004) Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100:950–957CrossRefPubMed
86.
Zurück zum Zitat Volante M, Cavallo GP, Papotti M (2004) Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid. Endocr Pathol 15:313–317CrossRefPubMed Volante M, Cavallo GP, Papotti M (2004) Prognostic factors of clinical interest in poorly differentiated carcinomas of the thyroid. Endocr Pathol 15:313–317CrossRefPubMed
87.
Zurück zum Zitat Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF (1984) Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 59:851–855PubMed Watson RG, Brennan MD, Goellner JR, van Heerden JA, McConahey WM, Taylor WF (1984) Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 59:851–855PubMed
88.
Zurück zum Zitat Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C (2005) Genetic classification of benign and malignant follicular neoplasm based on a 3-gene combination. J Clin Endocrinol Metab 90:2512–2521CrossRefPubMed Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C (2005) Genetic classification of benign and malignant follicular neoplasm based on a 3-gene combination. J Clin Endocrinol Metab 90:2512–2521CrossRefPubMed
89.
Zurück zum Zitat DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) WHO histological classification of thyroid and parathyroid tumours. World Health Organization classification of tumours. Pathology & genetics. Tumours of endocrine organs. IARC Press, Lyon, pp 49–123 DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) WHO histological classification of thyroid and parathyroid tumours. World Health Organization classification of tumours. Pathology & genetics. Tumours of endocrine organs. IARC Press, Lyon, pp 49–123
90.
Zurück zum Zitat Williams ED, Doniach I, Bjarnson O, Michie W (1977) Thyroid cancer in an iodine rich area. Cancer 39:215–222PubMedCrossRef Williams ED, Doniach I, Bjarnson O, Michie W (1977) Thyroid cancer in an iodine rich area. Cancer 39:215–222PubMedCrossRef
91.
Zurück zum Zitat Williams ED (2000) Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8:181–183PubMedCrossRef Williams ED (2000) Guest editorial: two proposals regarding the terminology of thyroid tumors. Int J Surg Pathol 8:181–183PubMedCrossRef
92.
Zurück zum Zitat Wynford-Thomas D (1994) Thyroid cancer. In: Lemoine N, Neoptolemos J, Cooke T (eds) Cancer. A molecular approach. Blackwell Scientific Publications, Oxford, pp 192–222 Wynford-Thomas D (1994) Thyroid cancer. In: Lemoine N, Neoptolemos J, Cooke T (eds) Cancer. A molecular approach. Blackwell Scientific Publications, Oxford, pp 192–222
93.
Zurück zum Zitat Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aiyoshi Y, Uchida K (2004) Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin Cancer Res 10:2035–2043CrossRefPubMed Yano Y, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aiyoshi Y, Uchida K (2004) Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid carcinoma. Clin Cancer Res 10:2035–2043CrossRefPubMed
Metadaten
Titel
How to define follicular thyroid carcinoma?
verfasst von
Kurt Werner Schmid
Nadir Rashad Farid
Publikationsdatum
01.04.2006
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 4/2006
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-006-0162-0

Weitere Artikel der Ausgabe 4/2006

Virchows Archiv 4/2006 Zur Ausgabe

Neu im Fachgebiet Pathologie

Open Access 21.02.2024 | Fettleber | Originalien

Herausforderungen der Automation bei der quantitativen Auswertung von Leberbiopsien

Automatische Quantifizierung von Leberverfettung

21.02.2024 | Thrombozytopenie | CME

Knochenmarkhistologie bei Zytopenien

Beitrag zur hämatologischen Differenzialdiagnostik

Open Access 19.02.2024 | Künstliche Intelligenz | Originalien

Die Modelltransferierbarkeit von KI in der digitalen Pathologie

Potenzial und Realität